These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20107930)
21. Hepatitis with interface inflammation and IgG, IgM, and IgA anti-double-stranded DNA antibodies following infliximab therapy: comment on the article by Charles et al. Saleem G; Li SC; MacPherson BR; Cooper SM Arthritis Rheum; 2001 Aug; 44(8):1966-8. PubMed ID: 11508453 [No Abstract] [Full Text] [Related]
22. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. Caso F; Cantarini L; Morisco F; Del Puente A; Ramonda R; Fiocco U; Lubrano E; Peluso R; Caso P; Galeazzi M; Punzi L; Scarpa R; Costa L Expert Opin Biol Ther; 2015 May; 15(5):641-50. PubMed ID: 25652590 [TBL] [Abstract][Full Text] [Related]
23. Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment. Björnsson HK; Gudbjornsson B; Björnsson ES J Hepatol; 2022 Jan; 76(1):86-92. PubMed ID: 34487751 [TBL] [Abstract][Full Text] [Related]
24. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. Tobin AM; Kirby B BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy. Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833 [TBL] [Abstract][Full Text] [Related]
26. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [TBL] [Abstract][Full Text] [Related]
27. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Williams VL; Cohen PR Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984 [TBL] [Abstract][Full Text] [Related]
29. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases. Rodrigues S; Lopes S; Magro F; Cardoso H; Horta e Vale AM; Marques M; Mariz E; Bernardes M; Lopes J; Carneiro F; Macedo G World J Gastroenterol; 2015 Jun; 21(24):7584-8. PubMed ID: 26140007 [TBL] [Abstract][Full Text] [Related]
30. Severe bout of cutaneous psoriasis in a patient with psoriasic arthritis undergoing treatment with infliximab. Uriarte Itzazelaia E; Hernando I; Prada A; Alonso A Clin Exp Rheumatol; 2007; 25(4):659. PubMed ID: 17888230 [No Abstract] [Full Text] [Related]
31. Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis. Wahie S; Alexandroff A; Reynolds NJ Clin Exp Dermatol; 2006 May; 31(3):460-1. PubMed ID: 16681606 [No Abstract] [Full Text] [Related]
32. Infliximab in psoriasis and psoriatic arthritis. Papoutsaki M; Osório F; Morais P; Torres T; Magina S; Chimenti S; Costanzo A BioDrugs; 2013 Jan; 27 Suppl 1():13-23. PubMed ID: 23990278 [TBL] [Abstract][Full Text] [Related]
33. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases]. Benucci M; Nenci G; Cappelletti C; Manfredi M Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615 [TBL] [Abstract][Full Text] [Related]
34. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481 [TBL] [Abstract][Full Text] [Related]
35. Myocarditis associated with infliximab: a case report and review of the literature. Slattery E; Ismail N; Sheridan J; Eustace K; Harewood G; Patchett S Inflamm Bowel Dis; 2011 Jul; 17(7):1633-4. PubMed ID: 21674722 [No Abstract] [Full Text] [Related]